Pro-nociceptive role of the activation of mineralocorticoid receptor in the pathogenesis of painful diabetic neuropathy

被引:5
作者
Dong, Fei [1 ]
He, Xijing [1 ]
机构
[1] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Orthoped Surg, Sch Med, Xian 710004, Shaanxi, Peoples R China
关键词
GLUCOCORTICOIDS; EPLERENONE; BLOCKADE; RATS; SKIN; INFLAMMATION; ALDOSTERONE; MECHANISMS; EXPRESSION; CYTOKINES;
D O I
10.1016/j.mehy.2013.06.003
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Patients with diabetic neuropathy may develop severe pain which persists over several years, resulting from impaired nerve endings in the skin, which originate the pain signals of diabetic neuropathy. Inflammatory processes have been implicated in the genesis and maintenance of chronic pain. The activation of the mineralocorticoid receptor (MR) is believed to promote classical inflammation features such as high levels of oxidative metabolites and proinflammatory cytokines, tissue destruction. Selectively blocking MR's can prevent the development of pain behaviors induced by neuroinflammation. Since proinflammatory cytokines and mediators were found to have increased in diabetic skin, we propose MR activation may play a pro-nociceptive role in diabetic neuropathy through local inflammation of the skin. Research methods examining MR overexpression in normal skin and selectively blocking MR in the diabetic skin are useful in identifying whether MR activation may bring cutaneous nerve insult and to explain whether MR activation is involved in the progression of painful diabetic neuropathy. If proven, this hypothesis would indicate the MR may potentially act as a novel target for pain therapeutics. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:436 / 438
页数:3
相关论文
共 24 条
  • [1] Prevalence and Characteristics of Painful Diabetic Neuropathy in a Large Community-Based Diabetic Population in the UK
    Abbott, Caroline A.
    Malik, Rayaz A.
    van Ross, Ernest R. E.
    Kulkarni, Jai
    Boulton, Andrew J. M.
    [J]. DIABETES CARE, 2011, 34 (10) : 2220 - 2224
  • [2] Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network
    Bookout, Angie L.
    Jeong, Yangsik
    Downes, Michael
    Yu, Ruth T.
    Evans, Ronald M.
    Mangelsdorf, David J.
    [J]. CELL, 2006, 126 (04) : 789 - 799
  • [3] Mineralocorticoid Receptor Blocker Eplerenone Reduces Pain Behaviors In Vivo and Decreases Excitability in Small-diameter Sensory Neurons from Local Inflamed Dorsal Root Ganglia In Vitro
    Dong, Fei
    Xie, Wenrui
    Strong, Judith A.
    Zhang, Jun-Ming
    [J]. ANESTHESIOLOGY, 2012, 117 (05) : 1102 - 1112
  • [4] Microvascular Reactivity and Inflammatory Cytokines in Painful and Painless Peripheral Diabetic Neuropathy
    Doupis, John
    Lyons, Thomas E.
    Wu, Szuhuei
    Gnardellis, Charalambos
    Dinh, Thanh
    Veves, Aristidis
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (06) : 2157 - 2163
  • [5] The mineralocorticoid receptor as a novel player in skin biology: beyond the renal horizon?
    Farman, Nicolette
    Maubec, Eve
    Poeggeler, Burkhard
    Klatte, Jennifer E.
    Jaisser, Frederic
    Paus, Ralf
    [J]. EXPERIMENTAL DERMATOLOGY, 2010, 19 (02) : 100 - 107
  • [6] Sensitized peripheral nociception in experimental diabetes of the rat
    Fuchs, D.
    Birklein, F.
    Reeh, P. W.
    Sauer, S. K.
    [J]. PAIN, 2010, 151 (02) : 496 - 505
  • [7] Blockade of mineralocorticoid receptor reverses adipocyte dysfunction and insulin resistance in obese mice
    Hirata, Ayumu
    Maeda, Norikazu
    Hiuge, Aki
    Hibuse, Toshiyuki
    Fujita, Koichi
    Okada, Takuya
    Kihara, Shinji
    Funahashi, Tohru
    Shimomura, Iichiro
    [J]. CARDIOVASCULAR RESEARCH, 2009, 84 (01) : 164 - 172
  • [8] THE MINERALOCORTICOID RECEPTOR DISCRIMINATES ALDOSTERONE FROM GLUCOCORTICOIDS INDEPENDENTLY OF THE 11-BETA-HYDROXYSTEROID DEHYDROGENASE
    LOMBES, M
    KENOUCH, S
    SOUQUE, A
    FARMAN, N
    RAFESTINOBLIN, ME
    [J]. ENDOCRINOLOGY, 1994, 135 (03) : 834 - 840
  • [9] Miana M, 2011, J PHYSIOL PHARMACOL, V62, P87
  • [10] Diabetic Painful and Insensate Neuropathy: Pathogenesis and Potential Treatments
    Obrosova, Irina G.
    [J]. NEUROTHERAPEUTICS, 2009, 6 (04) : 638 - 647